Neuroinflammation can be assessed by evaluating different aspects of microglia and astrocytes in the central nervous system (CNS). Some key assays include glial activation, proinflammatory cytokine concentrations, blood-brain barrier permeability, and neuronal viability. CNS injury, brain infection, toxins, autoimmune diseases, and other conditions may all lead to the aberrant release of inflammatory factors. Neuroinflammation is a potential mechanism underlying Alzheimer's disease and other neurological disorders.

Creative Biolabs' neuroinflammation assays are efficient and accurate scientific tools that can assist researchers in understanding the biology of neurological disorders and screening prospective lead candidates. https://neuros.creative-biolabs.com/neuroinflammation-assay.htm